May FDA Pipeline

Article

New medical devices, FDA actions and first-time generics

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Zoryve Cream 0.05% for Young Children with Atopic Dermatitis

FDA Approves Zoryve Cream 0.05% for Young Children with Atopic Dermatitis

Briana Contreras
October 10th 2025
Article

Read More

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

October 10th 2025
Podcast

Listen

FDA Expands Approval of Opzelura Cream to Children Ages 2 to 11 with Atopic Dermatitis

FDA Expands Approval of Opzelura Cream to Children Ages 2 to 11 with Atopic Dermatitis

Briana Contreras
October 10th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
October 10th 2025
Podcast

Listen

Research Shows Hidradenitis Suppurativa Impacts 1% Globally, With Women More Affected

Research Shows Hidradenitis Suppurativa Impacts 1% Globally, With Women More Affected

Briana Contreras
October 10th 2025
Article

Read More

New Data at EADV Could Offer Hope, Address Gaps in Dermatology Care

New Data at EADV Could Offer Hope, Address Gaps in Dermatology Care

Briana Contreras
October 10th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.